Some Traders Bet on Q2 Rebounds for Biotech ETFs

The first quarter was not kind to biotechnology stocks and exchange traded funds. The SPDR S&P Biotech ETF (NYSEArca: XBI), the third-largest biotechnology ETF, and the iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB), the largest biotech exchange traded fund by assets, had an average...